location icon

pageTitle

Approximately 74% of patients who completed the 14 weeks of PoNS Treatment™ in the Long-Term Treatment Trial experienced significant improvement in their balance1.

The patients enrolled in the clinical trials suffered from a mild-to-moderate traumatic brain injury (mmTBI, including concussion or post-concussive syndrome) within the last year of the start of the study. They were still experiencing chronic balance deficit, which is demonstrated by symptoms such as dizziness, difficulty walking, trouble climbing stairs, and/or difficulty completing everyday tasks. They were between the ages of 18-65 years old and were fit enough to walk unassisted for 20 minutes or more.

Kim Skinner, PT, DPT
Director of Physical Therapy, Helius Medical Technologies

“As the lead physiotherapist involved in the clinical trials, I saw firsthand some of the most impactful and meaningful changes that participants experienced. As a result of improvements in their balance and gait, they were able to perform independent self-care tasks such as dressing, showering, walking up and down the driveway, and going grocery shopping.”

Head Shot Kim Skinner 1024x683

What is the clinical evidence supporting PoNS TreatmentTM for TBI patients?

In patients with chronic balance deficit due to mild-to-moderate traumatic brain injury (mmTBI, including concussion or post-concussive syndrome), PoNS™ was studied in conjunction with targeted physical therapy in two clinical trials involving 165 patients1,2

Of those who completed the 14 weeks of PoNS Treatment™ in the Long-Term Treatment Trial, approximately 74% of patients experienced significant improvement in their balance¹. Patients also showed meaningful improvements in their gait and walking endurance, which they maintained after the 12-week withdrawal of treatment2.

Both clinical trial results to date indicate the effectiveness of the PoNS™ device, when paired with physical exercise, to meaningfully improve the balance and gait of most patients after their mmTBI1,2.

Where can I find more information?

Translingual Neurostimulation for the Treatment of Chronic Symptoms Due to Mild-to-Moderate Traumatic Brain Injury

Archives of Rehabilitation Research and Clinical Translation | September 27, 2019

A Prospective, Multicenter Study to Assess the Safety and Efficacy of Translingual Neurostimulation Plus Physical Therapy for the Treatment of a Chronic Balance Deficit Due to Mild‐to‐Moderate Traumatic Brain Injury

Neuromodulation: Technology at the Neural Interface | March 23, 2020

Translingual Neural Stimulation with the Portable Neuromodulation Stimulator (PoNS™) Induces Structural Changes Leading to Functional Recovery in Patients with Mild-to-Moderate Traumatic Brain Injury

European Medical Journal: Radiology | September 1, 2020

If you are a clinician seeking detailed information regarding the clinical evidence, please contact us. 

How do I get in touch with a clinic that offers PoNS TreatmentTM?

PoNS TreatmentTM is exclusively offered by authorized clinics across Canada with more opening soon.

References:
1. Helius Medical Technologies. Data on File. 2019 Post Hoc Analysis – Long Term Treatment Trial – Responder rate – Pharma Data Associates
2. Tyler M, et al. Arch Res Rehabil Clin Transl. 2019; 1(3-4):10026.

Sign-up to find out more about:

  • PoNS Treatment™ experience from other physical therapists and clinicians
  • Future clinics to offer PoNS Treatment™
  • New indications
  • New publications
Form by ChronoForms - ChronoEngine.com